October 1, 2020Open Access

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy

Key Points

Key points are not available for this paper at this time.

Abstract

In summary, these results demonstrated that CD47/SIRPα blocking peptides, pep-20 and its derivate, could serve as promising candidates to promote macrophages-mediated phagocytosis and immune response in cancer immunotherapy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Hongfei Wang

Yixuan Sun

Xiuman Zhou

Journals

SHILAP Revista de lepidopterología

Journal for ImmunoTherapy of Cancer

Actions

Institutions

Sun Yat-sen University

Zhengzhou University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study